Now on
Inhaled teicoplanin completed phase 1 clinical trial in cystic fibrosis
Inhaled teicoplanin completed phase 1 clinical trial in cystic fibrosis
FDA grants ODD for the use of teicoplanin in Staphylococcus aureus infections in cystic fibrosis patients
FDA grants Orphan Drug Designation for the use of teicoplanin in Staphylococcus aureus infections in cf patients.
Wellcome Trust supports the development of sirolimus in beta- thalassemia, a collaborative project between Rare Partners and Ferrara University
Wellcome Trust supports the development of sirolimus in beta - thalassemia, a collaborative project between Rare Partners and Ferrara University
Orphan Drug Designation for the treatment of sickle cell disease also in USA
Sirolimus has been granted Orphan Drug Designation for the treatment of sickle cell disease also in USA
Orphan Drug Designation to sirolimus in Sickle Cell Disease
Orphan Drug Designation to sirolimus in Sickle Cell Disease